Researchers have identified neutralizing antibodies against Zika virus from an infected patient that fully protected mice from infection, adding to the current arsenal of antibodies in development for much needed antiviral therapies and vaccines. Unlike other human antibodies under investigation that recognize both Zika and the closely related dengue virus, the antibodies used in this study exclusively target Zika, demonstrating a high specificity that could be important in avoiding potential side effects - such as enhanced dengue infection in regions where both viruses are endemic.
Overall view of antibody Z23 bound to the Zika virus particle. Courtesy of Gao et al., Science Translational Medicine (2016)
Researchers have identified neutralizing antibodies against Zika virus from an infected patient that fully protected mice from infection, adding to the current arsenal of antibodies in development for much needed antiviral therapies and vaccines. Unlike other human antibodies under investigation that recognize both Zika and the closely related dengue virus, the antibodies used in this study exclusively target Zika, demonstrating a high specificity that could be important in avoiding potential side effects - such as enhanced dengue infection in regions where both viruses are endemic.
The 2015 outbreak of Zika virus disease, a mosquito-borne infection linked to a birth defect known as microcephaly in babies, has spread to more than 80,000 people in 69 countries and regions worldwide. Zika is fortunately no longer considered an international public health emergency, according to the World Health Organization, but an urgent need for preventative and treatment approaches, none of which has been clinically approved, remains.
Here, Qihui Wang and colleagues isolated 13 monoclonal antibodies from the blood of a Zika virus-infected patient returning from Venezuela to China. Two of these antibodies (known as Z23 and Z3L1) potently eliminated Zika virus in vitro, without cross-reacting with dengue virus strains, and shielded mice completely from Zika virus infection. Structural analysis suggests that the antibodies block infection by targeting sites on the virus' envelope protein, which aids viral entry into cells. Further analysis is necessary to better understand how Z23 and Z3L1 specifically offer protection, the authors say.
Source: American Association for the Advancement of Science
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.